# DNA Hypomethylating Agents and Lenalidomide in Elderly Patients With Myeloid Malignancies in the US

> **NCT02863458** · — · WITHDRAWN · sponsor: **The Cleveland Clinic**

## Conditions studied

- Acute Myeloid Leukemia
- Myelodysplastic Syndromes

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02863458
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-09-01
- **Primary completion:** 2020-09-30
- **Final completion:** 2020-09-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study was a data review, no patient recruitment occurred.
- **Last updated:** 2023-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02863458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02863458, "DNA Hypomethylating Agents and Lenalidomide in Elderly Patients With Myeloid Malignancies in the US". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02863458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*